Related Experiment Video

Updated: Apr 28, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.1K

Conjugate Vaccines Targeting Tumor-Associated Carbohydrate Antigens

Nadine Rosenglick1, Géraud Valentin1, Kiran Marineni1

  • 1Department of Chemistry and Biochemistry, School of Green Chemistry and Engineering, University of Toledo, 2801 W. Bancroft St., Toledo, OH 43606, USA.

Vaccines
|April 27, 2026
PubMed

Insights

Cancer cells have unique carbohydrates (TACAs) targeted for immunotherapy. Despite early setbacks with TACA-protein conjugate vaccines, new strategies and carriers are improving anticancer vaccine development.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Cancer cells express tumor-associated carbohydrate antigens (TACAs) on their surface.
  • TACAs facilitate tumor growth, immune evasion, and metastasis.
  • TACA-protein conjugate vaccines were developed for targeted cancer immunotherapy.

Purpose of the Study:

  • To review efforts to overcome limitations of early TACA-protein conjugate vaccines.
  • To explore advancements in anticancer vaccine design and delivery.

Main Methods:

  • Review of two decades of research on overcoming TACA vaccine limitations.
  • Analysis of novel vaccine components: TACA analogues, mimics, clusters, glycopeptides.
  • Evaluation of new vaccine carriers for improved delivery and reduced interference.

Main Results:

  • Early TACA vaccines (e.g., sTn-KLH) failed due to poor immunogenicity and TACA heterogeneity.
  • Significant progress has been made in developing conformation-locked TACA mimics and multivalent vaccines.
  • New vaccine carriers offer modularity and reduced immune interference.

Conclusions:

  • Overcoming limitations of early TACA vaccines is crucial for effective cancer immunotherapy.
  • A diverse toolbox of advanced strategies and carriers now exists for improved anticancer vaccine design.
  • Future anticancer vaccines hold promise for enhanced efficacy through refined TACA presentation and delivery.
Keywords:
T-cell independenceantigencancerconjugate vaccineimmunotherapytumor-associated carbohydrate antigenvaccine carrier

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.4K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

6.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K